Analysis of suscebility genes and pathogenesis of HTLV-I-associated Sjogren's syndrome
Analysis of suscebility genes and pathogenesis of HTLV-I-associated Sjogren's syndrome
批准号:
13557042
负责人:
EGUCHI Katsumi
金额:
$6.46万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
HTLV-I has been identified as a causative agent which initiates and/or perpetuates the process of Sjogren's syndrome (SS). A high seroprevalence of HTLV-I infection has been determined in SS patients in the HTLV I-endemic area of Nagasaki, Japan. Many patients with HTLV-I-associated myelopathy (HAM/TSP) have been complicated with SS. The present study was undertaken to clarify the involvement of HTLV-I infection on the development or perpetuation of SS. At first, we analyzed promoter region polymorphisms of the IL-10 gene. Our results suggest that the presence of the ATA haplotype of the IL-10 gene are associated with an increased susceptibility to primary SS. Moreover, IL-10 gene promoter region polymorphism affects the age at onset of SS, and the amounts of serum IgG. However, there is no association between the presence of anti-HTLV-I antibodies and IL-10 gene polymorphism. Next, two-color analysis by flow cytometry revealed a significantly high percentage of IL-12Rβl^+ cells in CD4 … More ^+T lymphocytes in HAM/TSP patients compared to the control. These results suggest Th1 immune activation in patients with HAM/TSP, which leads to chronic inflammation in the tissues, mediated by dysregulation of the IL-12/IL-12R. Furthermore, the sLe^<x+>+ cell population, which has features of activated Th1 cells with up-regulated expression of E-selectin and P-selectin ligands mediated by HTLV I infection, is increased in peripheral blood CD4^+T lymphocytes in HAM/TSP patients. These findings suggest their involvement in transmigration of T lymphocytes from peripheral blood into tissues. In addition, our results indicate that peripheral blood CD4^+T lymphocytes of HAM/TSP patients are resistant to apoptosis triggered through mitochondrial death pathway through up-regulations of expression of anti-apoptotic protein, Bcl-xL. We used HTLV-I tax transfectants to show that tax-mediated induction of Bcl-xL expression can protect cells from apoptotic stimuli in a mitochondria-dependent fashion. Compared with tax-negative JPX-9 cells, Bcl-xL expression was clearly augmented in tax-positive JPX-9 cells. These cells were resistant to both receptor-mediated apoptosis and chemical induced apoptosis. Theses results suggest that tax-mediated Bcl-xL expression inhibit apoptosis of activated T lymphocytes in HTLV-I-seropositive subjects, which consequently promotes the onset of autoimmune disorders such as SS. Finally, we demonstrated the expression of TLR-2, TLR-3 and TLR4 on the acinal and ductal cells, and infiltrated mononuclear cells from minor salivary glands of SS. When a human salivary glands (HSG) cell line were stimulated by peptidoglycan, poly I : C, or LPS, HSG cell line augmented the expression of CD54 and production of IL-6, through the phosphorylation of MAP kinase. From the above findings, the development and/or perpetuation of SS might be implicated with HTLV-I infection and the susceptibility genes. Less
期刊论文(359)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Eguchi K.: "Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis."Intern Med. 41. 77-78 (2002)
Eguchi K.:“系统性红斑狼疮并发巨细胞病毒诱导的噬血细胞综合征和结肠炎。”实习医学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawakami A, et al.: "Role of HTLV-I infection in the pathogenesis of Sjogren's syndrome and rheumatoid arthritis."Mod Rheumatol. 11. 87-90 (2001)
Kawakami A 等人:“HTLV-I 感染在干燥综合征和类风湿性关节炎发病机制中的作用。”Mod Rheumatol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ida H: "Granzyme B leakage-induced cell death: a new type of activation -induced natural killer cell death"J Immunol. (accepted).
Ida H:“颗粒酶 B 渗漏诱导的细胞死亡:一种新型的激活诱导的自然杀伤细胞死亡”J Nutrition。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yanagi K: "Immuno-gene therapy with adenoviruses expressing fms-like tyrosine kinase 3 ligand and CD40 ligand for mouse hepatoma cells in vivo"Int J Oncol. 22. 345-351 (2003)
Yanagi K:“用表达 fms 样酪氨酸激酶 3 配体和 CD40 配体的腺病毒对体内小鼠肝癌细胞进行免疫基因治疗”Int J Oncol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawakami A: "Modulation of the expression of membrance-bound CD54(mCD54) and soluble from of CD54(sCD54) in endothelial cells by glucosyl transferase inhibitor;"Biochem Biophys Res Commun. 296・1. 26-31 (2002)
Kawakami A:“通过葡萄糖基转移酶抑制剂调节内皮细胞中膜结合CD54(mCD54)和可溶性CD54(sCD54)的表达”;Biochem Biophys Res Commun.296·1。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 155 条
Role of innate immunity on initiation of autoimmune diseases and its regulation
-
批准号:15390316
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.96万
-
财政年份:2003
-
负责人:EGUCHI Katsumi
-
依托单位:
Mechanisms of immunoregulation by serine proteinase inhibitor and its application of therapy for rheumatic disease
-
批准号:13670461
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2001
-
负责人:EGUCHI Katsumi
-
依托单位:
Role of Fas mediated apoptosis in the process of autoimmune thyroid diseases : possible involvement of Fas ligand (FasL) expression in breakdown of "immunoprevileged site" formation
-
批准号:11671091
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.79万
-
财政年份:1999
-
负责人:EGUCHI Katsumi
-
依托单位:
Role of HTLV-I on pathegenesis of Sjogren's syndrome
-
批准号:09670482
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1997
-
负责人:EGUCHI Katsumi
-
依托单位:
ROLE OF HUMAN T LYMPHOTROPIC VIRUS TYPE I ON PATHOGENESIS OF SJOGREN'S SYNDROME
-
批准号:07670534
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:EGUCHI Katsumi
-
依托单位:
Role of adult T cell lymphotropic virus 1 on pathogenesis of Sjogren's syndrome.
-
批准号:05670426
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1993
-
负责人:EGUCHI Katsumi
-
依托单位:
Role of HTLV-I infection in development of chronic inflammatory arthropathy.
-
批准号:02670285
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1990
-
负责人:EGUCHI Katsumi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
草鱼NF-κB p50与IL-10启动子的结合特性及其调控效应
-
批准号:2026JJ60378
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:阳鸿
-
依托单位:
基于"热证可灸"理论的中药联合铺棉灸治疗带状疱疹急性期的临床疗效及对血清SP、β-EP、IL-6、IL-10、NSE水平的影响
-
批准号:2026JJ81075
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄迎春
-
依托单位:
IL-10通过STAT3磷酸化编码调控椎间盘退变中“保护-病理”双重效应的机制研究
-
批准号:2026JJ82659
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:汤亮
-
依托单位:
IL-10和PD-1双通路对乙肝表面抗原滴度快速下降的影响及其对乙肝临床治愈率的预测价值研究
-
批准号:JCZRLH202600212
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肠道菌群产物丁酸通过GPR43上调BLIMP1促进T细胞产生IL-10改善过敏性哮喘
-
批准号:2026JJ81782
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄劼
-
依托单位:
HES1与IL-10 mRNA双修饰人脐带间充质干细胞在急性脑出血治疗中的作用及机制研究
-
批准号:JCZRLH202600095
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
“蠲痰止哮饮”治疗支气管哮喘慢性持续期(痰浊阻肺证 )的临床观察及对 IL-10 、lL-17 的影响
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:重庆市垫江县中医院
-
依托单位:
草鱼IL-10基因变异的炎症调控作用特点与育种价值评估
-
批准号:2025JJ40023
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吕钊
-
依托单位:
基于IL-10靶点治疗肺纤维化海洋先导化合物的发现与作用机制研究
-
批准号:2024Y9710
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:毕丽伟
-
依托单位:
肠道菌群通过GLP-1/STAT3/IL-10信号轴促进肠道巨噬细胞
M2极化改善肠外营养相关肠屏障损伤的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位: